Abstract:Background: Processes that drive Alzheimer's disease pathogenesis have long been considered to occur within the central nervous system, yet recent studies have bolstered the possibility that changes in the periphery may be relevant to the disease process. Accumulating evidence has suggested that proteins changing in the blood may be reliable indicators of disease within the brain. Recent advances in geroscience have identified potential mechanisms of blood-brain communication that modulate brain function in ways that could be harnessed for therapy. While blood-borne proteins associated with either youth or old age have been targeted to restore function to the aged brain, it remains unclear whether other dysfunctional systemic states can be exploited for similar benefits. Here we investigate whether APOE allelic variation or presence of brain amyloid are associated with distinct proteomic changes within the systemic environment and what molecular processes are associated with these changes. Methods: Using the SOMAscan assay, we measured 1,305 plasma proteins from 53 homozygous APOE3 and APOE4 subjects (mean age = 68 years; minimum = 54 years) who exhibited no cognitive impairment, some of whom can be categorized as harboring cerebral amyloid based on cerebrospinal fluid A{beta}42 measurements. Using the Dream R package for linear mixed effects modeling, we investigated possible contributions of either the APOE-{epsilon}4 allele or amyloid positivity to changes in the plasma proteome. Ontology-based pathway and module trait correlation analyses were performed to understand disrupted pathways that vary based on APOE genotype or amyloid positivity. Results: We found that expression of the APOE-{epsilon}4 allele produced distinct changes in the composition of the plasma proteome. Using both pathway enrichment analysis and weighted gene co-expression network analysis, we found that plasma proteins associated with APOE4 expression were linked to pathways related to atherosclerosis, lipid transport, the extracellular matrix, and synaptogenesis signaling. Independent of APOE4, we found that cognitively normal, amyloid-positive subjects exhibit distinct plasma proteome signatures associated with pathways previously linked to AD pathology, relative to amyloid-negative controls. Harboring brain amyloid was associated with plasma proteomic changes linked to dysfunction in blood-brain barrier and other neural cell types. Our results indicate that changes in the plasma proteome are related to possession of AD risk alleles, as well as the presence of amyloid pathology in subjects prior to the onset of symptoms. This work highlights the possibility that pathways in the systemic environment in certain risk contexts may be plausible targets to explore for modulating disease.

Physical activity predicts reduced plasma β amyloid in the Cardiovascular Health Study

Associations of Physical Activity Engagement with Cerebral Amyloid-β and Tau from Midlife

The impact of exercise on blood-based biomarkers of Alzheimer’s disease in cognitively unimpaired older adults

Association of Physical Activity, Brain Volume, and Plasma Biomarkers of Alzheimer’s Disease: the Shanghai Aging Study

The Association of Plasma Amyloid-β and Cognitive Decline in Cognitively Unimpaired Population

Non-linear Relationship Between Plasma Amyloid-β 40 Level and Cognitive Decline in a Cognitively Normal Population

Non-Linear Relationship Between Plasma Amyloid-Beta 40 Level And Cognitive Decline In A Cognitively Normal Population

The Relationship Between Physical Activity and Non-Modifiable Risk Factors on Alzheimer's Disease and Brain Health Markers: A UK Biobank Study

Non‐linear relationship between plasma amyloid‐β 40 level and cognitive decline in a cognitively normal population: Biomarkers (non‐neuroimaging) / plasma/serum/urine biomarkers

Effects of Aerobic Exercise on Plasma AT(N) Biomarkers

Effect of Physical Activity on Cognitive Function in Older Adults at Risk for Alzheimer Disease: A Randomized Trial

[The Plasma Level of Amyloid-Β is Associated with Cognitive Decline: a Two Years Follow-Up Study in Xi'an Rural Areas].

Microglial Correlates of Late Life Physical Activity: Relationship with Synaptic and Cognitive Aging in Older Adults

Physical Activity Is Associated with Slower Cognitive Decline in Older Adults with Type 2 Diabetes

Associations of Physical Activity with Alzheimer’s Disease Pathologies and Cognition: the CABLE Study

Plasma adiponectin levels predict cognitive decline and cortical thinning in mild cognitive impairment with beta-amyloid pathology

Cia_a_357994 555..565

Physical Activity, Cognitive Activity, and Cognitive Decline in a Biracial Community Population

Physical activity and the maintenance of cognitive function

APOE genotype or presence of brain amyloid alters the plasma proteome in cognitively normal, elderly subjects

Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging